Dr. Der-Yuan Chen, is a specialist of Allergy, Immunology, Rheumatology. He earned as an excellent Dr. of CMUH (2022), the Master Award from Taiwan College of Rheumatology (TCR) (2023) and Asia-Pacific League of Associations of Rheumatology (APLAR) (2024). He serves as the director/vice superintendent of Rheumatology/Immunology Center of CMUH. He served as President of TCR (2014-2016). His research interests include immunopathogenesis of autoimmune diseases (SLE, RA) and autoinflammatory disease (AOSD), an association of infection with immune-mediated inflammatory diseases, and the safety profile of biological/targeted synthetic DMARDs. With an excellent achievement in SLE research, he has won the SLE Academic Research Award from the Society of Immunology and participated in the development of APLAR guidelines for SLE treatment (Lancet Rheumatology 2022). He has thirty-five AOSD-related papers published in SCI journals, including Ann Rheum Dis and Arthritis Rheumatol, and also by Kelly's textbooks of Rheumatology. He has been awarded an outstanding researcher by various organizations. With 265 peer-reviewed publications in SCI Journals (~2025.01), He was listed as one of the World’s Top 2% Scientists in 2020-2024 [Citation: 11,100, H-index: 55 and i10-index: 209 (Google Scholar, 2025.01)]